Citations

Mayo Clinic

Showing 10 of 108551 citations.

The Stiff Left Atrium Is to Atrial Fibrillation as the Stiff Left Ventricle Is to Diastolic Heart Failure
Naqvi, Tasneem Z.

Circulation: Arrhythmia and Electrophysiology | March 11, 2016 | Volume: 9 | Issue: 3 | Pages: No page available

10.1161/circep.116.003952 | PMID 26966289 Get It

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Emile, Jean‐François , Abla, Oussama , Fraitag, Sylvie , Horne, AnnaCarin , Haroche, Julien , Requena‐Caballero, Luis, Jordan, Michael B. , Allen, Carl E. , Charlotte, Frédéric , Egeler, R. Maarten , Herrera, Juana Gil, Henter, Jan‐Inge , Jankú, Filip , Mérad, Miriam , Rollins, Barret J., Tazi, Abdellatif , Vassallo, Robert , Weiss, Lawrence M. , Astigarraga, Itziar , Donadieu, Jean , Abdel‐Wahab, Omar , Diamond, Eli L. , Fischer, Alain , Picarsic, Jennifer , Rodríguez‐Galindo, Carlos , Vassallo, Robert , Emile, Jean-François , Allen, Carl E

Blood | March 10, 2016 | Volume: 127 | Issue: 22 | Pages: 2672-2681

10.1182/blood-2016-01-690636 | PMID 26966089 Get It

Abstract The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.
Outcomes of double-balloon enteroscopy-assisted direct percutaneous endoscopic jejunostomy tube placement
Al‐Bawardy, Badr , Gorospe, Emmanuel C., Alexander, Jeffrey A. , Bruining, David H. , Rajan, Elizabeth , Song, Louis Wong Kee, Wong Kee Song, Louis M, Coelho–Prabhu, Nayantara

Endoscopy | March 10, 2016 | Volume: 48 | Issue: 06 | Pages: 552-556

10.1055/s-0042-101853 | PMID 26964079 Get It

Prevention, Diagnosis, and Treatment of Postthrombotic Syndrome
Jain, Atul , Cifu, Adam S.

JAMA | March 10, 2016 | Volume: 315 | Issue: 10 | Pages: 1048

10.1001/jama.2016.0225 | PMID 26954414 Get It

Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement
Edwards, Fred H., O’Brien, Sean M. , Mack, Michael J. , Shahian, David M. , Grover, Frederick L., Tuzcu, E. Murat , Thourani, Vinod H. , Carroll, John D. , Brennan, James M. , Brindis, Ralph G. , Rumsfeld, John, Holmes, David R. , Douglas, Pamela S. , Cohen, David Jonathan , Peterson, Eric D. , Douglas, Pamela S

JAMA Cardiology | March 10, 2016 | Volume: 1 | Issue: 1 | Pages: 46

10.1001/jamacardio.2015.0326 | PMID 27437653 Get It

Fecal Microbiome in Epidemiologic Studies—Response
Vogtmann, Emily , Amir, Amnon , Shi, Jianxin , Flores, Roberto , Knight, Rob , Chia, Nicholas , Sinha, Rashmi R. , Chen, Jun , Sampson, Joshua N. , Chia, Nicholas

Cancer Epidemiology, Biomarkers & Prevention | March 10, 2016 | Volume: 25 | Issue: 5 | Pages: 870-871

10.1158/1055-9965.epi-16-0161 | PMID 26961994 Get It

Mycobacterium arupense, Mycobacterium heraklionense, and a Newly Proposed Species, “Mycobacterium virginiense” sp. nov., but Not Mycobacterium nonchromogenicum, as Species of the Mycobacterium terrae Complex Causing Tenosynovitis and Osteomyelitis
Vasireddy, Ravikiran, Vasireddy, Sruthi, Brown‐Elliott, Barbara A. , Wengenack, Nancy L. , Eke, Uzoamaka A , Benwill, Jeana L., Turenne, Christine Y. , Wallace, Richard J. , Turenne, Christine Y

Journal of Clinical Microbiology | March 10, 2016 | Volume: 54 | Issue: 5 | Pages: 1340-1351

10.1128/jcm.00198-16 | PMID 26962085 Get It

ABSTRACT Mycobacterium terrae complex has been recognized as a cause of tenosynovitis, with M. terrae and Mycobacterium nonchromogenicum reported as the primary etiologic pathogens. The molecular taxonomy of the M. terrae complex causing tenosynovitis has not been established despite approximately 50 previously reported cases. We evaluated 26 isolates of the M. terrae complex associated with tenosynovitis or osteomyelitis recovered between 1984 and 2014 from 13 states, including 5 isolates reported in 1991 as M. nonchromogenicum by nonmolecular methods. The isolates belonged to three validated species, one new proposed species, and two novel related strains. The majority of isolates (20/26, or 77%) belonged to two recently described species: Mycobacterium arupense (10 isolates, or 38%) and Mycobacterium heraklionense (10 isolates, or 38%). Three isolates (12%) had 100% sequence identity to each other by 16S rRNA and 99.3 to 100% identity by rpoB gene region V sequencing and represent a previously undescribed species within the M. terrae complex. There were no isolates of M. terrae or M. nonchromogenicum , including among the five isolates reported in 1991. The 26 isolates were susceptible to clarithromycin (100%), rifabutin (100%), ethambutol (92%), and sulfamethoxazole or trimethoprim-sulfamethoxazole (70%). The current study suggests that M. arupense , M. heraklionense , and a newly proposed species (“ M. virginiense ” sp. nov.; proposed type strain MO-233 [DSM 100883, CIP 110918]) within the M. terrae complex are the major causes of tenosynovitis and osteomyelitis in the United States, with little change over 20 years. Species identification within this complex requires sequencing methods.
Creating Order From Chaos
Kancharla, Krishna , Asirvatham, Samuel J. , Kapa, Suraj , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | March 10, 2016 | Volume: 9 | Issue: 3 | Pages: No page available

10.1161/circep.116.003939 | PMID 26962095 Get It

Multiple Volar Carpometacarpal Dislocations: Case Report/Review of the Literature
Cates, Robert A. , Rhee, Peter C. , Kakar, Sanjeev

Journal of Wrist Surgery | March 10, 2016 | Volume: 05 | Issue: 03 | Pages: 236-240

10.1055/s-0036-1580602 | PMID 27468376 Get It

Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody Data
Gonzales, Manuel Moreno , Bentall, Andrew , Kremers, Walter K. , Stegall, Mark D. , Borrows, Richard , Stegall, Mark D , Bentall, Andrew , Kremers, Walter K

Journal of the American Society of Nephrology | March 9, 2016 | Volume: 27 | Issue: 10 | Pages: 3165-3174

10.1681/asn.2015070811 | PMID 26961348 Get It

The ability to predict outcomes for individual patients would be a significant advance for not only counseling, but also identifying those for whom interventions may be needed. The goals of this study were to validate an existing risk prediction score that incorporates easily obtainable clinical factors and determine if histologic findings at 1-year surveillance biopsy and/or serum donor–specific alloantibody status could improve predictability of graft loss by 5 years. We retrospectively studied 1465 adults who received a solitary kidney transplant between January of 1999 and December of 2008 and had sufficiently detailed 5-year follow-up data for modeling. In this cohort, the Birmingham risk model (incorporating recipient factors at 1 year, including age, sex, ethnicity, renal function, proteinuria, and prior acute rejection) predicted death–censored and overall graft survival (c statistics =0.84 and 0.78, respectively). The presence of glomerulitis or chronic interstitial fibrosis (g and ci scores by Banff, respectively) on 1-year biopsy specimens independently correlated with graft loss by 5 years. Adding these variables to the model for death–censored graft loss increased predictability (c statistic =0.90), improved calibration (ability to stratify risk from high to low), and reclassified risk of failure in 29% of patients. Adding the presence of donor-specific alloantibody at 1 year did not improve predictability or reclassification but did improve calibration marginally. We conclude that, at 1 year after kidney transplant, a risk model of graft survival that incorporates clinical factors and histologic findings at surveillance biopsy is highly predictive of individual risk and well calibrated.